Table 4.
Adjusted odds ratios of LBW by multivariate analysis of predictor variables.
| Predictor variable | aOR (95% CI) | P value |
|---|---|---|
| Maternal age | 1.02 (0.978-1.064) | 0.362 |
| EMT | ||
| 7.5<EMT ≤ 12 | 1 | |
| EMT ≤ 7.5 | 2.179 (1.305-3.640) | 0.003* |
| EMT >12 | 0.584 (0.403-0.844) | 0.004* |
| Maternal BMI | 1.004 (0.971-1.039) | 0.799 |
| Infertility duration | 0.969 (0.916-1.026) | 0.284 |
| Parity | ||
| 0 | 1 | |
| ≥1 | 0.776 (0.469-1.286) | 0.325 |
| FET cycle rank | ||
| 0 | 1 | |
| ≥1 | 0.866 (0.654-1.147) | 0.315 |
| Infertility type | ||
| Primary | 1 | |
| Secondary | 0.801 (0.617-1.038) | 0.093 |
| Infertility cause | ||
| Female factor | 1 | |
| Male factor | 1.189 (0.852-1.659) | 0.309 |
| Mixed | 0.952 (0.667-1.358) | 0.785 |
| Unexplained | 1.311 (0.809-2.123) | 0.272 |
| Fertilization type | ||
| IVF | 1 | |
| ICSI | 0.956 (0.708-1.29) | 0.767 |
| Endometrial preparation protocols | ||
| NC | 1 | |
| HRT | 1.152 (0.811-1.636) | 0.431 |
| GnRH agonist-HRT | 1.084 (0.74-1.589) | 0.678 |
| No. of transferred embryos | ||
| 1 | 1 | |
| 2 | 1.149 (0.897-1.471) | 0.271 |
| Stage of embryo transferred | ||
| Cleavage stage | 1 | |
| Blastocyst stage | 1.254 (0.953-1.65) | 0.106 |
| No. of good-quality embryo transfer | ||
| 0 | 1 | |
| ≥1 | 1.087 (0.865-1.367) | 0.475 |
| Cesarean delivery | ||
| No | 1 | |
| Yes | 1.082 (0.824-1.421) | 0.570 |
| Newborn gender | ||
| Male | l | |
| Female | 1.474 (1.182-1.838) | 0.001* |
| Pregnancy complications | ||
| No | 1 | |
| Yes | 7.075 (5.591-8.953) | <0.001* |
Adjustment included maternal age, maternal BMI, infertility duration, parity, FET, cycle rank, infertility type, infertility cause, fertilization type, endometrial preparation protocols, number of transferred embryos, stage of embryo transferred, number of good-quality embryo transfer, cesarean delivery, newborn gender and pregnancy complications. aOR, adjust odds ratio; CI, confidence interval; BMI, body mass index; FET, frozen embryo transfer; EMT, endometrial thickness; IVF, in vitro fertilization; ICSI, intracytoplasmic sperm injection; NC, natural cycle; HRT, hormone replacement therapy; GnRH, gonadotropin-releasing hormone.
*P < 0.05 was considered statistically significant.